Brief: Enochian Biosciences Inc - Acquired Exclusive License For Innovative Technology To Potentially Treat And Prevent All Variants Of Coronavirus
June 21 (Reuters) - Enochian Biosciences Inc ENOB.O :
* ENOCHIAN BIOSCIENCES INC - ACQUIRED EXCLUSIVE LICENSE FOR
INNOVATIVE TECHNOLOGY TO POTENTIALLY TREAT AND PREVENT ALL
VARIANTS OF CORONAVIRUS
* ENOCHIAN BIOSCIENCES INC - REQUEST FOR A PRE-INVESTIGATOR
NEW
DRUG MEETING FOR COVID-19 TREATMENT WILL BE SUBMITTED TO FDA IN
NEAR TERM
Source text for Eikon: ID:nGNE2yls1V
Further company coverage: ENOB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lunai Bioworks
See all newsNASDAQ RESUMED AT 02:16 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:06 PM
Brief: Lunai Bioworks Expands Parkinson's Platform Through Exclusive Tanaist Agreement
Brief: Lunai Bioworks Signs Agreement With Brainstorm Therapeutics
Brief: Lunai Bioworks - Regains Nasdaq Compliance With Minimum $1 Bid Price Rule - SEC Filing